Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs.
Open Access
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 262 (5), 2187-2189
- https://doi.org/10.1016/s0021-9258(18)61637-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1986
- Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAVScience, 1986
- Biochemical heterogeneity of reverse transcriptase purified from the AIDS virus, HTLV‐IIIFEBS Letters, 1986
- Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1986
- In search of specific inhibitors of retrovirus replicationAntiviral Research, 1985
- Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virionsVirology, 1985
- Inhibition of HTLV-III/LAV replication by foscarnetBiochemical Pharmacology, 1985
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985
- Isolation and characterization of a DNA primase from human mitochondria.Journal of Biological Chemistry, 1985
- Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells.Journal of Biological Chemistry, 1983